Article Text

THU0297 Prevalence and Clinical Significance of Severe Flares in a Cohort of Systemic Lupus Erythematosus
  1. R. López1,
  2. C. Erausquin1,
  3. C. Rodríguez-Lozano1,
  4. A. Naranjo1,
  5. S. Ojeda1,
  6. F. Francisco1,
  7. J. C. Quevedo1,
  8. L. Cáceres1,
  9. M. García-Bello2,
  10. I. Rúa-Figueroa1
  1. 1Rheumatology
  2. 2Research Unit, Hospital Dr Negrín, Las Palmas de Gran Canaria, Spain


Background Systemic Lupus Erythematosus (SLE) is a systemic autoinmune disorder of relapsing-remitting nature. However, we don´t have enough knowing about severe flare´s relevance on damage, severity or death in SLE patients.

Objectives To analyze the cumulative incidence and clinical significance of severe flares (SF) in a monocentric, well characterized SLE cohort.

Methods Cumulative clinical data were retrospectively collected at the moment of the last assessment. SF was defined using Selena-Sledai Flare Index (SFI) tool. Persistently active disease was not considered. SLICC/ACR/DI (SDI) was used to assess damage. Fisher exact test was used for qualitative variables and Kruskal-Wallis for quantitative ones. We compared patients with SF with patients without SF antecedents using bivariate analysis, and also analyzed the impact of SF on SLE-related mortality.

Results We studied 286 SLE patients (1997 ACR criteria); 3 patients were excluded by insufficient data about flare; 283 were finally included. Female: 91%; caucasian 94.5 %; mean age 48.5 (±13.3); mean SLE duration: 17.1 (±8.8) years; mean follow-up 14.3 (±10.2) years. Median SLE criteria: 6.0 (5.0-7.0); major organ involvement 49 %; class III or IV (OMS) lupus nephritis : 30%; hospitalization by SLE:64 %; median SLICC/ACR/DI 1.0 (0.0 2.0): 7.8 % of the patients had died at the study moment. Severe infection (SInf): 32% hospitalization by SInf : 30%. Cumulative treatment: 84% had received antimalarials at any time, 81%, corticosteroids (≥ 60mg/day: 45 %) and 54 % inmunosupressants; 272 (96.4%) patients had ≥1 flare, median 2 (IQR:1-3). Median SF:1.00 (IQI:0-2), (range: 0-13), mean: 1.4. Median SF per year:0.073 (IQR:0.00-0.17). SF was associated to more damage, Sinf, hospitalization by SInf, more number of hospitalization by infectionand number of SLE criteria (table1).

Conclusions In our SLE cohort, a history of severe flare was associated to dead, more damage and severe infection.

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.